FIELD: pharmaceuticals.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry and is the pharmaceutical composition for topical administration of dermatomycoses containing the 3-ethoxycarbonyl-5-(4-chlorobenzylidene)thiazolidine-2,4-dione as the active ingredient, the vaseline oil and emulsion wax are used as the auxiliary components, they are characterized by the fact that, as the auxiliary components they comprise the water-soluble chitosan and water.
EFFECT: invention allows to obtain the stable, non-exfoliable medicinal form.
2 cl, 10 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING MYCOTIC DISEASES | 2014 |
|
RU2563811C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FUNGAL DISEASE AND METHOD FOR ITS PREPARING | 2005 |
|
RU2295958C1 |
| HYBRID ETHERS BASED ON DERIVATIVES OF THIAZOLIDINE-2,4-DIONA AND AZOLES (1H-1,3-IMIDAZOLE AND 1H-1,3,4-TRIAZOLE) AND APPLICATION THEREOF | 2017 |
|
RU2662153C1 |
| NEW POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND TRIAZOLE | 2023 |
|
RU2814730C1 |
| 3,5-SUBSTITUTED THIAZOLIDINE-2,4-DIONE DERIVATIVES, HAVING ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2690161C1 |
| BENZYLIDENETHIAZOLIDINE-2,4-DIONES SHOWING ANTIMICROBIAL ACTIVITY | 1986 |
|
SU1417436A1 |
| HYBRID AMIDES BASED ON TRIAZOLE AND THIAZOLIDINE HAVING ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2703997C1 |
| REMEDY WITH ANTIFUNGAL ACTIVITY BASED ON METAL SOLS | 2021 |
|
RU2763885C1 |
| HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIFUNGAL ACTION | 2016 |
|
RU2621156C1 |
